Binge Eating Disorder Creates Significant Health Care Burden

This article originally appeared here.
Share this content:
Binge Eating Disorder Creates Significant Health Care Burden
Binge Eating Disorder Creates Significant Health Care Burden

THURSDAY, May 14, 2015 (HealthDay News) -- Health care costs are similar for patients with binge eating disorder (BED) and those with eating disorder not otherwise specified without BED (EDNOS-only), and are significantly higher compared with costs of matched patients without an eating disorder (NED), according to a study published online May 8 in the International Journal Eating Disorders.

Brandon K. Bellows, Pharm.D., from VA Salt Lake City Health Care System, and colleagues compared one-year health care costs and utilization for adult patients with BED and EDNOS. Data were included for 257 BED patients, 743 EDNOS-only patients, and 823 NED patients, matched for age, sex, body mass index, depression diagnosis, and index month of first diagnosis.

The researchers found that in 2011 U.S. dollars, the mean total one-year costs were $33,716, $37,052, and $19,548 for BED, EDNOS-only, and NED patients, respectively. BED patients had higher one-year total health care costs compared with EDNOS-only ($5,589 higher; P = 0.06) and matched NED patients ($18,152 higher; P < 0.001), after adjustment for patient characteristics.

"Patients with BED had significantly higher total health care costs than patients with NED, indicating that BED places a significant burden on the health care system," the authors write.

Several authors disclosed financial ties to pharmaceutical companies. The study was funded by Shire Development and Anolinx.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »